IL-12 Genetically Engineered Myeloid Cells in Participants With Relapsed, Refractory Solid Tumors
IL-12 Genetically Engineered Myeloid Cells in Participants With Relapsed, Refractory Solid Tumors
Recruiting · NCT07672483 · Registry updated 2026-10-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| IL-12 Genetically Engineered Myeloid Cells in Participants With Relapsed, Refractory Solid Tumors | Refractory Solid Tumor Malignancies; Relapsed Solid Tumor Malignancies | Recruiting | Phase 1 | 2026-10-09 | NCT07672483 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Cancer Institute (NCI) | 3015 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| National Institutes of Health Clinical Center | Bethesda | United States | 800 |